Gastroenterology
Volume 136, Issue 3 , Pages 763-766 , March 2009

Bak to Basics of Colonocyte Renewal

  • Nathan J. Susnow

      Affiliations

    • Gastroenterology/Hepatology Division, Department of Medicine, University of Washington, Seattle, Washington
    • Corresponding Author InformationReprint requests Address requests for reprints to: Nathan J. Susnow, MD, Gastroenterology/Hepatology Division, Department of Medicine, University of Washington, Box 356424, Suite AA103, 1959 NE Pacific Street, Seattle, Washington 98195-6424. fax: (206) 764-2147
    • ,
  • David M. Hockenbery

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

References 

  1. Maskens AP, Dujardin-Loits RM. Kinetics of tissue proliferation in colorectal mucosa during post-natal growth. Cell Tissue Kinet. 1981;14:467–477
  2. Eastwood GL. Gastrointestinal epithelial renewal. Gastroenterology. 1977;72:962–975
  3. Cai WB, Roberts SA, Potten CS. The number of clonogenic cells in crypts in three regions of murine large intestine. Int J Radiat Biol. 1997;71:573–579
  4. Merritt AJ, Potten CS, Watson AJ, et al. Differential expression of bcl-2 in intestinal epithelia (Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia). J Cell Sci. 1995;108:2261–2271
  5. Hockenbery DM, Zutter M, Hickey W, et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991;88:6961–6965
  6. Lakshman M, Subramaniam V, Jothy S. CD44 negatively regulates apoptosis in murine colonic epithelium via the mitochondrial pathway. Exp Mol Pathol. 2004;76:196–204
  7. Pritchard DM, Potten CS, Korsmeyer SJ, et al. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo. Oncogene. 1999;18:7287–7293
  8. Hoyes KP, Cai WB, Potten CS, et al. Effect of bcl-2 deficiency on the radiation response of clonogenic cells in small and large intestine, bone marrow and testis. Int J Radiat Biol. 2000;76:1435–1442
  9. Pritchard DM, Print C, O'Reilly L, et al. Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine. Oncogene. 2000;19:3955–3959
  10. Wilson JW, Potten CS. Immunohistochemical localization of BAX and BAD in the normal and BCL-2 null gastrointestinal tract. Apoptosis. 1996;1:183–190
  11. di Masi A, Antoccia A, Dimauro I, et al. Gene expression and apoptosis induction in p53-heterozygous irradiated mice. Mutat Res. 2006;594:49–62
  12. Duckworth CA, Pritchard DM. Suppression of apoptosis, crypt hyperplasia and altered differentiation in the colonic epithelia of bak-null mice. Gastroenterology. 2009;136:943–952
  13. Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res. 1996;56:2849–2855
  14. Lindsten T, Ross AJ, King A, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2000;6:1389–1399
  15. Janumyan Y, Cui Q, Yan L, et al. G0 function of BCL2 and BCL-xL requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation. J Biol Chem. 2008;283:34108–34120
  16. Liberman E, Naumov I, Kazanov D, et al. Malignant transformation of normal enterocytes following downregulation of Bak expression. Digestion. 2008;77:48–56
  17. Degenhardt K, Chen G, Lindsten T, et al. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell. 2002;2:193–203
  18. Krajewska M, Moss SF, Krajewski S, et al. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 1996;56:2422–2427
  19. Ogura E, Senzaki H, Yamamoto D, et al. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol Rep. 1999;6:365–369
  20. Sakamoto I, Yamada T, Ohwada S, et al. Mutational analysis of the BAK gene in 192 advanced gastric and colorectal cancers. Int J Mol Med. 2004;13:53–55
  21. Knudson CM, Johnson GM, Lin Y, et al. Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res. 2001;61:659–665
  22. Jamerson MH, Johnson MD, Korsmeyer SJ, et al. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. Br J Cancer. 2004;91:1372–1379
  23. Izeradjene K, Combs C, Best M, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. 2007;11:229–243
  24. Aiken KD, Roth KA. Temporal differentiation and migration of substance P, serotonin, and secretin immunoreactive enteroendocrine cells in the mouse proximal small intestine. Dev Dyn. 1992;194:303–310
  25. Haughn L, Hawley RG, Morrison DK, et al. BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation. J Biol Chem. 2003;278:25158–25165
  26. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727–730
  27. Gassler N, Roth W, Funke B, et al. Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing. Gastroenterology. 2007;133:587–598

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(09)00051-1

doi: 10.1053/j.gastro.2009.01.021

Gastroenterology
Volume 136, Issue 3 , Pages 763-766 , March 2009

Article Tools

* Image Usage & Resolution